ArticleApplied health economics and health policy2021

Does Biosimilar Bevacizumab Offer Affordable Treatment Options for Cancer Patients in the USA? A Budget Impact Analysis from US Commercial and Medicare Payer Perspectives.

Jingyan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.